Guy Nohra and Jacob Glanville discuss the advancements in vaccine technology, particularly focusing on universal vaccines and the challenges posed by evolving pathogens. They explore the role of computational immunology in understanding immune responses and the potential of AI in biotechnology. The discussion also addresses the current state of flu vaccines, the importance of clinical trials, and the need for transparent communication to rebuild public trust in vaccines.